Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cellular Pathology”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03720561
What this trial is testing

Evaluate Ibrutinib Retention in Chronic Lymphocytic Leukemia Participants Treated in a Real World Setting

Who this might be right for
Leukemia, Lymphocytic, Chronic, B-Cell
Janssen-Cilag S.p.A. 312
Not applicableStudy completedNCT07673666
What this trial is testing

GliomaAI-Astro23: MRI-Based Detection of IDH Mutant Astrocytoma (Grade 2 and 3)

Who this might be right for
GliomaGlioma (Diagnosis)Astrocytoma+4 more
Deep Learning Institute of Radiological Sciences 1,372
Not applicableStudy completedNCT03653676
What this trial is testing

Sickle Cell Pro-Inflammatory Response to Interval Training Study

Who this might be right for
Sickle Cell Disease
Ann & Robert H Lurie Children's Hospital of Chicago 110
Testing effectiveness (Phase 2)Study completedNCT00002674
What this trial is testing

Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia

Who this might be right for
Leukemia
Fred Hutchinson Cancer Center 30
Not applicableUnknownNCT04839159
What this trial is testing

Study of Biological Markers in Children With Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
Queen Fabiola Children's University Hospital 41
Early research (Phase 1)UnknownNCT04861779
What this trial is testing

HSK29116 in Adults With Relapsed/Refractory B-cell Malignancies

Who this might be right for
Relapsed/Refractory B-Cell Malignancies
Haisco Pharmaceutical Group Co., Ltd. 156
Not applicableNot Yet RecruitingNCT07693127
What this trial is testing

Red Blood Cell and Platelet Indices for Predicting Outcomes in Acute Exacerbations of COPD

Who this might be right for
Acute Exacerbation of Chronic Obstructive Pulmonary DiseaseChronic Obstructive Pulmonary Disease (COPD)AECOPD
Assiut University 50
Large-scale testing (Phase 3)Study completedNCT02053610
What this trial is testing

CLL11: A Study of Obinutuzumab (RO5072759 [GA101]) With Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia (Stage 2)

Who this might be right for
Lymphocytic Leukemia, Chronic
Hoffmann-La Roche 787
Testing effectiveness (Phase 2)Study completedNCT02128113
What this trial is testing

RTA 408 Ophthalmic Suspension for the Prevention of Corneal Endothelial Cell Loss Following Cataract Surgery - GUARD

Who this might be right for
Corneal Endothelial Cell LossOcular PainOcular Inflammation+1 more
Biogen 307
Early research (Phase 1)Study completedNCT05990920
What this trial is testing

Study of Allogeneic Blood-derived Natural Killer Cells to Evaluate Safety and Tolerability in Cancer Refractory to Conventional Therapy

Who this might be right for
Pathologically Confirmed Cancer Refractory to Conventional TherapyRefractory CancerMetastatic Cancer+5 more
NKGen Biotech, Inc. 6
Not applicableWithdrawnNCT00880386
What this trial is testing

Losartan in Treating Pulmonary Fibrosis in Patients With Stage I, II, or III Non-Small Cell Lung Cancer

Who this might be right for
DyspneaLung CancerPulmonary Complications+1 more
University of South Florida
Testing effectiveness (Phase 2)Looking for participantsNCT04588922
What this trial is testing

Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML

Who this might be right for
Hematologic Malignancies
Sellas Life Sciences Group 160
Post-approval studies (Phase 4)Study completedNCT01815918
What this trial is testing

Effect of Low Dose Corticosteroids on Perioperative Markers of Thrombosis and Fibrinolysis in Total Knee Arthroplasty

Who this might be right for
Total Knee Arthroplasty
Hospital for Special Surgery, New York 60
Large-scale testing (Phase 3)Study completedNCT01298323
What this trial is testing

Study to Determine if Contacting Patients With MTC More Frequently Results in Earlier Detection and Treatment of Signs and Symptoms of AEs and Thus a Decrease in the Percentage of Time Patients Experience AEs During First 12 Months on Vandetanib Treatment

Who this might be right for
Locally Advanced or Metastatic Medullary Thyroid CancerMedullary Thyroid Cancer
Sanofi 205
Testing effectiveness (Phase 2)Study completedNCT00514696
What this trial is testing

Study of the Safety of GCS-100 in Subjects With Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia
La Jolla Pharmaceutical Company 12
Testing effectiveness (Phase 2)Ended earlyNCT01500161
What this trial is testing

Pooled Unrelated Donor Umbilical Cord Blood Transplant For Hematologic Malignancy Needing Allogeneic Stem Cell Transplant Without Related HLA-Match

Who this might be right for
Acute Myelogenous LeukemiaAcute Lymphocytic LeukemiaChronic Lymphocytic Leukemia+6 more
Texas Oncology Cancer Center 1
Not applicableStudy completedNCT07103486
What this trial is testing

Evaluate the Therapeutic Benefit of Tisagenlecleucel Compared to Existing Standard of Care in German Adult Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma

Who this might be right for
Diffuse Large B-Cell Lymphoma
Novartis Pharmaceuticals 264
Early research (Phase 1)Ended earlyNCT02668770
What this trial is testing

Ipilimumab (Immunotherapy) and MGN1703 (TLR Agonist) in Patients With Advanced Solid Malignancies

Who this might be right for
Advanced CancersMelanoma
M.D. Anderson Cancer Center 28
Large-scale testing (Phase 3)Study completedNCT00037869
What this trial is testing

High Dose I-131 Metaiodobenzylguanidine(MIBG) for Metastatic Neuroendocrine Tumors

Who this might be right for
Neuroendocrine TumorsMetastases, Neoplasm
M.D. Anderson Cancer Center 15
Not applicableLooking for participantsNCT05334069
What this trial is testing

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAnn Arbor Stage I Lymphoma+59 more
Alliance for Clinical Trials in Oncology 2,000
Next Page